Metraipolis › archive › dc_cee018cfcaf6
Targeting the NF-κB Pathway in Cancer: Mechanisms, Resistance, and Therapeutic Potential Across Tumor Types — Europe PMC PMID:41305005
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41305005
- DOI
- 10.3390/ph18111764
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T09:38:24.085Z
- SHA-256 of the archived text
b1a2882b0b1fae402cd9a2a8db3ca73c2dc80ffabf4f056995bfc9086508b932- Stable URL of this page
https://metraipolis.com/documento/dc_cee018cfcaf6
How to cite
Targeting the NF-κB Pathway in Cancer: Mechanisms, Resistance, and Therapeutic Potential Across Tumor Types — Europe PMC PMID:41305005 — Europe PMC (en), https://europepmc.org/article/MED/41305005 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cee018cfcaf6 (Metraipolis archive dc_cee018cfcaf6, sha256 b1a2882b0b1fae402cd9a2a8db3ca73c2dc80ffabf4f056995bfc9086508b932)
BibTeX
@misc{dccee018cfcaf6,
title = {Targeting the NF-κB Pathway in Cancer: Mechanisms, Resistance, and Therapeutic Potential Across Tumor Types — Europe PMC PMID:41305005},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41305005},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cee018cfcaf6; sha256 b1a2882b0b1fae402cd9a2a8db3ca73c2dc80ffabf4f056995bfc9086508b932},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41305005. Agents can read the archived copy with the MCP tool read_document.